SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
xiaoyu
Lv3
380 积分
2023-12-25 加入
最近求助
最近应助
互助留言
[Chinese expert consensus: multidisciplinary diagnosis and treatment of multiple ground-glass nodule like lung cancer (2024 edition)]
5天前
已完结
Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) Maintenance as Monotherapy or in Combination With Bevacizumab (BEV) for Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Chemotherapy
10天前
已完结
Immunotherapy or antiangiogenic therapy plus chemotherapy as first‐line treatment of patients with PD‐L1 (‐) advanced non‐squamous non‐small cell lung cancer in a Chinese cohort
10天前
已完结
Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective
11天前
已完结
Neoadjuvant Chemo-Immunotherapy for Early-Stage Non–Small Cell Lung Cancer
11天前
已完结
Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterations
11天前
已完结
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy
11天前
已完结
Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer
11天前
已完结
Validation Study for the N Descriptor of the Newly Proposed 9th Edition of the TNM Staging System Proposed by the International Association for the Study of Lung Cancer
11天前
已完结
Perioperative Immunotherapy for Node-Negative Non-Small Cell Lung Cancer – Current Evidence and Future Directions
11天前
已完结
没有进行任何应助
不需要了【积分已退回】
11天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论